Bill > S06736

This bill requires Medicaid in New York to cover a specific type of wearable medical device that uses low-intensity, alternating electric fields to treat glioblastoma (an aggressive form of brain cancer) and other cancers. The coverage would be based on recommendations from medical and scientific evidence, including three key sources of guidance: (1) medical device indications approved by the Federal Food and Drug Administration, (2) Centers for Medicare and Medicaid Services national and local coverage determinations, and (3) clinical practice guidelines from recognized organizations like the National Comprehensive Cancer Network and the American Society of Clinical Oncology. The bill would amend the social services law to add this coverage requirement, and it would take effect on the first of April following its enactment. By mandating this coverage, the bill aims to improve access to innovative cancer treatment technologies for Medicaid recipients in New York.

Budget and Finance, Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/S6736